Article Detail - JE Part B
MolDX: Breast Cancer Index (BCI) Gene Expression Test (L37822) - R5 - Effective July 3, 2025
Date Posted: July 3, 2025
This MolDX Local Coverage Determination (LCD) has been revised under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).
Effective Date: July 3, 2025
Summary of Changes:
Under Bibliography revised the broken hyperlink for the 21st reference and changes were made to citations to reflect AMA citation guidelines.
Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCD or access it via the CMS Medicare Coverage Database (MCD).